Clinicaltrial Stock Market Invest

Companies
Gain Therapeutics Reveals Promising Phase 1 Data for GT-02287 at International Parkinson’s Congress Oct 1, 2024
Companies
Belite Bio Aims for Stargardt Disease Treatment Breakthrough With Tinlarebant in Japan Mar 23, 2024
Pharmaceuticals
Ibogaine's Potential in TBI Therapy Gains Momentum Amid Psychedelic Investment Wave Jan 8, 2024